Pliant announces the presentation of preclinical data and clinical data from the INTEGRIS-PSC Phase 2a trial of bexotegrast in patients with primary sclerosing cholangitis. These posters were presented at The Liver Meeting^®.

CARGO Therapeutics Announces Pricing of Initial Public Offering

Terremoto Biosciences Closes $175 Million Series B Financing

Flare Therapeutics to Present New Translational Data in Support of Clinical Candidate FX-909’s Phase 1 Development at SITC 2023 Annual Meeting

Asher Bio Presents Promising New Preclinical Data for Cis-targeted Cancer Immunotherapy AB821 at SITC Annual Meeting